Product image of Metformina Ipca (Metformin Hydrochloride) supplied by GNH India

Metformina Ipca

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Ipca (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina Ipca, is a biguanide presented as an oral tablet for oral administration. It lowers elevated blood glucose by reducing hepatic glucose output and enhancing peripheral insulin sensitivity, and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH India supplies Metformina Ipca as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality standards. The company ensures batch‑to‑batch consistency and complies with EU regulatory requirements for export.

Manufacturer / TM Owner

Ipca Productos Farmaceuticos Unipessoal Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina Ipca (metformin) is used in the management of disorders of glucose metabolism, primarily type 2 diabetes mellitus.

  • Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
  • Combination therapy with other antidiabetics: enhances overall glucose lowering when added to sulfonylureas, DPP‑4 inhibitors or insulin.
  • Adjunct to diet and exercise: supports lifestyle measures to achieve target blood‑glucose goals.

How It Works

  • Metformina Ipca exerts its antidiabetic effect by inhibiting hepatic gluconeogenesis, thereby decreasing hepatic glucose production, and by increasing peripheral insulin sensitivity in muscle and adipose tissue, which enhances glucose uptake and utilization without stimulating insulin secretion.

Side Effects

Metformina Ipca may cause a range of adverse reactions, most of which are related to the gastrointestinal system, while rare but serious events require prompt medical attention.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: loose stools, often transient.
  • Abdominal discomfort: cramping or pain.
  • Metallic taste: altered taste perception.
  • Loss of appetite: reduced desire to eat.
  • Flatulence: increased gas.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic acidosis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Hepatotoxicity: liver enzyme elevations.
  • Hypoglycemia: especially when combined with insulin or secretagogues.
  • Vitamin B12 deficiency: long‑term use may reduce B12 levels.
  • Acute pancreatitis: inflammation of the pancreas.

Precautions & Warnings

Before initiating Metformina Ipca, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Renal function assessment: check eGFR and avoid use in severe renal impairment.
  • Lactic acidosis risk: contraindicated in patients with significant hepatic disease or hypoxia.
  • Alcohol consumption: limit intake to reduce acidosis risk.
  • Pregnancy and lactation: discuss potential risks with a healthcare professional.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformina Ipca can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast media: may precipitate renal dysfunction and lactic acidosis.
  • Cimetidine: increases metformin plasma concentrations.
  • Nitrates: can potentiate the risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • Thiazide diuretics: can raise blood glucose levels.
  • ACE inhibitors or ARBs: monitor renal function and electrolytes.

Frequently Asked Questions

Metformina Ipca contains metformin hydrochloride and is used to improve blood‑glucose control in adults with type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents.

Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, which reduces the amount of glucose released by the liver, and by increasing insulin‑mediated glucose uptake in muscle and fat tissues, thereby improving overall insulin sensitivity.

The dosage of Metformina Ipca is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of metformin during pregnancy or lactation should be evaluated by a healthcare professional. While some guidelines allow limited use when benefits outweigh risks, the decision must be made on a case‑by‑case basis after consulting a physician.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformina Ipca belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors in its mechanism of reducing hepatic glucose output and enhancing insulin sensitivity. It is generally weight‑neutral and has a low risk of hypoglycemia when used alone.

Metformina Ipca should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiration date.

Metformina Ipca is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare provider.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, hypoxia, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformina Ipca is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving radiographic contrast studies that may affect kidney function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT